Interview with Rajiv Chopra, President DSM India & MD DSM Nutirtional…
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
Address: Windsor House, 401, Fourth Floor, | CST Road, Kalina | Mumbai 400098, India
Tel: + 91 22 4034 9100 / 101
Web: http://www.dsm.com/en_US/cworld/public/home/pages/home.jsp
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting
its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global markets such as food and
dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical
and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver
annual net sales of around € 9 billion. The company is listed on NYSE Euronext. More information can be
found at www.dsm.com.
DSM Nutritional Products is the world’s leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetic industries.
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
As managing director of India’s fifth largest pharmaceutical company, Zydus Cadila’s Sharvil Patel shares his insights on his impressive internationalization strategy with a special focus on the US where Zydus…
A successful commercial leader, Annaswamy Vaidheesh, president of OPPI, VP South Asia and managing director at GSK India, talks about the tremendous work that the local affiliate is doing in…
A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative approach is the key to enhancing their reputation, improving patient outcomes and…
Ashok Battacharya, executive director of the Indian affiliate of Takeda Pharmaceuticals, with 38 years experience in global Ppharmaceutical MNCs, discusses the top-notch reputation that Takeda has among physicians and patients…
Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder collaboration, Jawed Zia, country president of Novartis India, explains how co-marketing deals with…
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs facing loss of exclusivity in…
Alexandre Williams, founder and managing director of Athena, an international company with an Indian manufacturing basis specialized in life cycle products, provides insights into some key trends shaping India’s pharmaceutical…
As the founder and chairman of Alves Group, a key Indian player in medical devices with an extensive portfolio, Randolph Alves shares the challenges India needs to overcome to remain…
Dharmesh Shah, managing director of BDR Pharmaceuticals, a company with a strong expertise in oncology, intensive care, and other therapeutic areas, provides us with an insightful overview of the main…
For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of opportunity for a variety of reasons. Novartis India…
Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and emerging markets as well as the opportunities…
Nikhil Masurkar, executive director of Entod Pharmaceuticals, talks about the company’s ambition to invest in stem cell research and become market leaders in the field of ophthalmology in ten years’…
See our Cookie Privacy Policy Here
